Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Guarnotta

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|May 28, 2022
Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine SystemValentina Guarnotta, Roberta Amodei, Francesco Frasca, et al.
International Journal of Molecular Sciences|August 12, 2023
Irisin: A Possible Marker of Adipose Tissue Dysfunction in ObesityLaura Tomasello, Maria Pitrone, Valentina Guarnotta, et al.
Endocrine Connections|June 22, 2018
The metabolic outcomes of growth hormone treatment in children are gender specificAlessandro Ciresi, Stefano Radellini, Valentina Guarnotta, et al.
Therapeutic Advances in Endocrinology and Metabolism|September 7, 2019
Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life studyValentina Guarnotta, Mariagrazia Irene Mineo, Stefano Radellini, et al.
Frontiers in Endocrinology|August 11, 2018
Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic VariabilityValentina Guarnotta, Giulia Di Bella, Giuseppe Pillitteri, et al.
Diabetology & Metabolic Syndrome|May 16, 2018
Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysisValentina Guarnotta, Enrica Vigneri, Giuseppe Pillitteri, et al.
Clinical Endocrinology|March 20, 2013
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levelsAlessandro Ciresi, Marco Calogero Amato, Valentina Guarnotta, et al.
BMC Pregnancy and Childbirth|March 23, 2021
Maternal-foetal complications in pregnancy: a retrospective comparison between type 1 and type 2 diabetes mellitusValentina Guarnotta, Mariagrazia Irene Mineo, Emanuela Giacchetto, et al.
Frontiers in Immunology|February 7, 2025
Dual-release hydrocortisone treatment improves serum and peripheral blood mononuclear cell inflammatory and immune profiles in patients with autoimmune primary adrenal insufficiencyLaura Tomasello, Antonina Coppola, Giuseppe Pizzolanti, et al.
Endocrine|October 12, 2017
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?Valentina Guarnotta, Chiara Martini, Maria Vittoria Davì, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|May 28, 2022
Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine SystemValentina Guarnotta, Roberta Amodei, Francesco Frasca, et al.
International Journal of Molecular Sciences|August 12, 2023
Irisin: A Possible Marker of Adipose Tissue Dysfunction in ObesityLaura Tomasello, Maria Pitrone, Valentina Guarnotta, et al.
Endocrine Connections|June 22, 2018
The metabolic outcomes of growth hormone treatment in children are gender specificAlessandro Ciresi, Stefano Radellini, Valentina Guarnotta, et al.
Therapeutic Advances in Endocrinology and Metabolism|September 7, 2019
Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life studyValentina Guarnotta, Mariagrazia Irene Mineo, Stefano Radellini, et al.
Frontiers in Endocrinology|August 11, 2018
Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic VariabilityValentina Guarnotta, Giulia Di Bella, Giuseppe Pillitteri, et al.
Diabetology & Metabolic Syndrome|May 16, 2018
Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysisValentina Guarnotta, Enrica Vigneri, Giuseppe Pillitteri, et al.
Clinical Endocrinology|March 20, 2013
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levelsAlessandro Ciresi, Marco Calogero Amato, Valentina Guarnotta, et al.
BMC Pregnancy and Childbirth|March 23, 2021
Maternal-foetal complications in pregnancy: a retrospective comparison between type 1 and type 2 diabetes mellitusValentina Guarnotta, Mariagrazia Irene Mineo, Emanuela Giacchetto, et al.
Frontiers in Immunology|February 7, 2025
Dual-release hydrocortisone treatment improves serum and peripheral blood mononuclear cell inflammatory and immune profiles in patients with autoimmune primary adrenal insufficiencyLaura Tomasello, Antonina Coppola, Giuseppe Pizzolanti, et al.
Endocrine|October 12, 2017
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?Valentina Guarnotta, Chiara Martini, Maria Vittoria Davì, et al.
Pageof 8